ArticleJournal of applied statistics2025

A novel Phase II single-arm hybrid design to minimize trial duration and enhance subsequent Phase III trial success rate.

Jun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.